Instructions for use of Cinnabsin tablets No. 60
Composition
active substances: Cinnabaris D3, Echinacea D1, Hydrastis D3, Kalium bichromicum D3;
1 tablet contains Cinnabaris D3 25 mg, Echinacea D1 25 mg, Hydrastis D3 25 mg, Kalium bichromicum D3 25 mg;
excipients: lactose monohydrate, magnesium stearate, wheat starch.
Dosage form
Pills.
Main physicochemical properties: white or almost white, sometimes with individual dark dots, biplane tablets with a beveled edge.
Pharmacotherapeutic group
A complex homeopathic preparation.
Pharmacological properties
Cinnabsin is a homeopathic combination preparation. Cinnabaris quickly and reliably relieves such characteristic symptoms of sinusitis as headaches, lacrimation, and facial neuralgia. Hydrastis and Kalium bichromicum act mainly in the subacute and chronic course of the disease, which often occurs with prolonged sinusitis. All three ingredients help relieve swelling of the mucous membranes and restore nasal breathing. Echinacea contributes to the general support of the immune system.
Indication
Acute and chronic inflammation of the paranasal sinuses (sinusitis).
Contraindication
Do not use in children under 2 years of age, during pregnancy or in case of known hypersensitivity to chromium, Echinacea and other species of the Asteraceae family or to any of the components of the drug. For fundamental reasons, Cinnabsin should not be used in cases of: progressive systemic diseases (such as tuberculosis and sarcoidosis), systemic diseases of white blood cells (such as leukemia and leukemia), autoimmune diseases (such as inflammatory diseases of collagen tissue (collagenoses), multiple sclerosis), immunodeficiencies (including HIV infection), immunosuppression (such as after organ or bone marrow transplantation or chemotherapy) or chronic viral diseases.
Interaction with other medicinal products and other types of interactions
Unknown.
Application features
When using homeopathic medicines, temporary initial deterioration is possible. In this case, you should stop taking the medicine and consult a doctor.
There is a risk of possible anaphylactic reactions in atopic patients. Atopic patients should consult a doctor before using this medicine.
You should consult a doctor:
if there is facial swelling, fever or severe headache, if the acute condition does not improve or worsens within the first two days of treatment, if additional complaints appear.
The drug contains wheat starch, so patients with hypersensitivity or intolerance to gluten should not take this drug.
The drug contains lactose, therefore patients with rare hereditary forms of galactose intolerance, lactase deficiency or glucose-galactose malabsorption syndrome should not use the drug.
Use during pregnancy or breastfeeding
The drug should not be used during pregnancy due to the content of echinacea. If the patient is breastfeeding, a doctor should be consulted before using this medicine.
Ability to influence reaction speed when driving vehicles or other mechanisms
Does not affect.
Method of administration and doses
Children aged 2 to 5 years: in acute conditions - 1 tablet 3 times a day until the condition improves. For further treatment, continue to take 1 tablet 3 times a day;
children aged 6 to 11 years: in acute conditions - 1 tablet every 2 hours (but not more than
6 tablets per day) until the condition improves. For further treatment, take 1 tablet 3 times a day;
Adults and children over 12 years of age: in acute conditions - 1 tablet every hour (but not more than 12 tablets per day) until the condition improves. For further treatment, take 1-2 tablets 3 times a day.
For chronic conditions, children and adults take 1 tablet 3 times a day, the recommended duration of treatment is 4-6 weeks.
It is not recommended to take Cinnabsin for more than 4 weeks without consulting a doctor.
Take the tablets half an hour before or half an hour after a meal, allowing them to slowly dissolve in the mouth. For children under 3 years of age, it is recommended to dissolve the tablet in a small amount of water (for example, in a teaspoon) for ease of use.
Children
The drug is prescribed to children aged 2 years and older.
Overdose
In cases of overdose, an increase in the frequency of adverse reactions is possible.
Side effects
In case of increased salivation after taking Cinabsin, it is recommended to reduce the dose or discontinue the drug.
If any adverse reactions occur, discontinue use of the drug and consult a doctor.
Expiration date
5 years.
Do not use after the expiry date stated on the packaging.
Storage conditions
Store at a temperature not exceeding 25 ºC, out of the reach of children.
Packaging
20 tablets in a blister; 3 or 5 blisters in a cardboard box.
Vacation category
Without a prescription.
Producer
Deutsche Homoeopathie-Union DHU-Arzneimittel GmbH & Co. KG.
or
Dr. Gustav Klein GmbH & Co. KG/Dr. Gustav Klein GmbH & Co. KG
Address
Ottostrasse 24, 76227 Karlsruhe, Germany.
or
Steinenfeld 3, 77736 Zell am Harmersbach, Germany/Steinenfeld, 3, 77736 Zell am Harmersbach, Germany
